A regulatory perspective on the role of drug interactions in antiretroviral drug development.

Saved in:
Bibliographic Details
Title: A regulatory perspective on the role of drug interactions in antiretroviral drug development.
Authors: Struble KA; Office of New Drugs, Division of Antiviral Products, US Food and Drug Administration, Silver Spring, Maryland 20993, USA. kimberly.struble@fda.hhs.gov, Reynolds KS
Source: Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2008 May; Vol. 3 (3), pp. 325-9.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101264945 Publication Model: Print Cited Medium: Internet ISSN: 1746-6318 (Electronic) Linking ISSN: 1746630X NLM ISO Abbreviation: Curr Opin HIV AIDS Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1746-6318
DOI:10.1097/COH.0b013e3282f5f509